Transjugular Intrahepatic Portosystemic Shunt as the Treatment for Refractory Hepatic Hydrothorax with Portal Vein Thrombosis
Hepatic hydrothorax occurs in 4-12% of patients with liver cirrhosis, A part of patients with persisted hydrothorax resists conservative treatment, known as refractory hepatic hydrothorax (RHH). Portal vein thrombosis (PVT) is observed in about 2.1 16.2% patients with liver cirrhosis, which may aggr...
Saved in:
Published in | Chinese medical journal Vol. 130; no. 16; pp. 1999 - 2000 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
China
Medknow Publications and Media Pvt. Ltd
20.08.2017
Lippincott Williams & Wilkins Ovid Technologies Medknow Publications & Media Pvt Ltd Wolters Kluwer |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Hepatic hydrothorax occurs in 4-12% of patients with liver cirrhosis, A part of patients with persisted hydrothorax resists conservative treatment, known as refractory hepatic hydrothorax (RHH). Portal vein thrombosis (PVT) is observed in about 2.1 16.2% patients with liver cirrhosis, which may aggravate portal hypertension. |
---|---|
Bibliography: | 11-2154/R Hepatic hydrothorax occurs in 4-12% of patients with liver cirrhosis, A part of patients with persisted hydrothorax resists conservative treatment, known as refractory hepatic hydrothorax (RHH). Portal vein thrombosis (PVT) is observed in about 2.1 16.2% patients with liver cirrhosis, which may aggravate portal hypertension. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0366-6999 2542-5641 |
DOI: | 10.4103/0366-6999.211887 |